Skip to content
Search

Latest Stories

Distressed pharmacy sales to increase in 2024, property adviser Christie & Co predicts

Last year, 45 per cent of pharmacies were sold to first-time buyers and 55 per cent to independent contractors and regional multiple operators through the broker 

Specialist business property adviser, Christie & Co has predicted that 2024 will be a big year for pharmacy sector in the UK, thanks to the introduction of the £645 million investment and the Pharmacy First scheme.


However, an increase in distressed pharmacy sales is also expected this year, the broker stated in its Business Outlook 2024 report, published on Thursday (12 January).

The report reflects on the transactional activity and challenges of 2023 and forecasts what this year might bring across the industries in which the broker operates in, including the pharmacy sector.

Christie & Co said they saw a strong transactional activity across the pharmacy sector in 2023, despite ongoing operational challenges, and offers were accepted, on average, at 2.5 per cent above asking price.

They made more sales agreement over the year, but completion volumes declined by 15 per cent, largely due to ongoing delays in the change of ownership process, the report revealed.

Last year, 45 per cent of pharmacies were sold to first-time buyers and 55 per cent to independent contractors and regional multiple operators through the broker.

A noticeable rise in the number of distressed pharmacy sales was seen in the second half of the year, driven by the continued pressures faced by contractors, and this trend is expected to continue throughout 2024, according to the property adviser.

Tony Evans, Head of Pharmacy at Christie & Co, commented: “2024 will no doubt be a big year for pharmacy. The introduction of the £645 million additional services funding and the successful rollout of the Pharmacy First style minor ailments scheme will no doubt provide much-needed additional income in offering some respite to contractors.

“However, the key driver to the future viability of the sector will be the successful outcome of the wider funding agreement to replace that previously agreed as part of the Community Pharmacy Contractual Framework’s 5-year deal in 2019.”

Also, it is predicted that there will be continued interest from existing operators, particularly for defensive purchases, and opportunities for investors and those with finance who are looking to enter the pharmacy market.

Pharmacies remained a preferred lending sector, with significant borrowing opportunities, according to Christie & Co’s Business Outlook 2024 report.

LloydsPharmacy disposals led to a surge in pharmacy transactions in 2023, putting pressure on lenders, valuers, solicitors, and NHS England, causing inevitable delays in the sales process, it stated.

Furthermore, the company’s annual sentiment survey revealed that while 46 per cent of pharmacy professionals are positive about 2024, It’s either neutral or negative about what’s to come for the rest 55 per cent.

About 85 per cent of the respondents (pharmacy professionals across the country) said they are planning to either buy or sell this year.

More For You

GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less
Swizzels’ Easter range, including Squashies Drumchick and Sweet Shop Favourite tubs

PDA members will get the chance to vote from this week

Pic credit: iStock

PDA to inform its members to vote “no” in Royal College of Pharmacy proposals

A vote to create a potential Royal College of Pharmacy needs to be called off as the current proposals would lead to “irreversible change to the identity and purpose” of the sector’s professional leadership body, according to the Pharmacy Defence Association (PDA).

From March 13th to March 24th, The Royal Pharmaceutical Society’s members will take part in a Special Resolution Vote (SRV) which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity.

Keep ReadingShow less
Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less